HYPR Hyperfine, Inc.
USHealthcareAs of 2026-07-08 16:00
Why HYPR matters now
Hyperfine, Inc. (HYPR) is a US stock in Healthcare. The latest InvestLog snapshot shows $1.12 with -8.61% on the session and $93.9M in market capitalization; recent performance reads 1-month +13.48% and YTD +63.38%.
The latest financial table shown here is Q1 2026, with revenue of $3.9M, net income of $-8.6M, and EPS of $-0.09. Investors can compare that operating picture with valuation signals such as P/E unavailable and FCF yield -21.3%.
The latest indexable market news headline is "Hyperfine Announces European Launch of Next-Generation Swoop® System" from Business Wire.
Additional event context on this page matters because analyst consensus is Buy with a median target of $1.60; recent insider activity includes Wolterman Dan filing A-Award. These signals are research inputs, not a recommendation.
Valuation
P/E (TTM)
—
PEG
—
P/B
4.55
P/S
8.79
EV/EBITDA
-3.24
DCF Value
$-1.35
FCF Yield
-21.3%
Div Yield
0.0%
Margins & Returns
Gross Margin
51.2%
Operating Margin
-226.6%
Net Margin
-226.9%
ROE
-101.3%
ROA
-57.6%
ROIC
-68.9%
Financials
| Period | Revenue | Net Income | EPS |
|---|---|---|---|
| Q1 2026 | $3.9M | $-8.6M | $-0.09 |
| Q4 2025 | $5.3M | $-5.9M | $-0.06 |
| FY 2025 | $13.6M | $-35.6M | $-0.43 |
| Q3 2025 | $3.4M | $-11.0M | $-0.14 |
Analyst Ratings
Consensus
Buy
Target (Consensus)
$1.60
Target (Median)
$1.60
Target Range
$1.60 - $1.60
Trading Activity
Insider Trades
Related Stocks
Latest News
Company Info
Sector
Healthcare
Industry
Medical - Devices
Country
US
Exchange
—
Beta
1.38
Headquartered in Guilford, Connecticut, Hyperfine, Inc. commenced operations in 2014. The firm develops and supplies imaging, monitoring, and magnetic resonance imaging (MRI) technologies. A key offering is its Swoop Portable MR imaging system, which utilizes integrated hardware and software services to meet a vital requirement for point-of-care medical diagnostics.